Education Library

Jay Giri, MD, discusses the pros, cons, and best uses for five types of observational database analyses.

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

Aditya Bharadwaj, MD, walks through the first PROTECT IV case enrolled at Loma Linda University Health Care in California.

Babar Basir, MD, discusses how hemodynamics can help clinicians decide whether to use mechanical circulatory support (MCS) in patients undergoing high-risk PCI.

Mihas Kodenchery, MD, and Laura Rodriguez, NP, discuss the low mortality and low complication rates in their high-volume high-risk PCI practice.
 

Bobby Yeh, MD, discusses how real-world evidence factors into treatment decisions made every day in clinical practice.

Navin Kapur, MD, discusses the latest science underlying reperfusion and unloading and how it led to the STEMI-DTU pilot and pivotal trials.

Kate Kearney, MD, discusses studies and strategies for revascularization in heart failure with reduced ejection fraction.

Mario Iannaccone, MD, discusses his meta-analysis data supporting pre-PCI placement of Impella® for AMI cardiogenic shock.

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

Ziad Ali, MD, presents a case study illustrating imaging-guided PCI in the context of high-risk Protected PCI at the CRT 2021 virtual annual symposium.